Free shipping on all orders over $ 500

Panitumumab

Cat. No. M1503

All AbMole products are for research use only, cannot be used for human consumption.

Panitumumab Structure
Synonym:

ABX-EGF

Size Price Availability Quantity
100ug USD 125 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Panitumumab is a fully human IgG2 monoclonal antibody specific to the epidermal growth factor receptor (EGFR). Panitumumab works by binding to the extracellular domain of the EGFR preventing its activation. This results in halting of the cascade of intracellular signals dependent on this receptor. The pharmacokinetics (PK) of panitumumab shows the so-called target-mediated disposition behavior.

Product Citations
Chemical Information
Molecular Weight 144321.76
Formula C6398H9878N1694O2016S48
CAS Number 339177-26-3
Storage -80°C for long term
References

[1] Douillard JY, et al. N Engl J Med. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.

[2] Wells A Messersmith, et al. Clin Cancer Res . Panitumumab, a monoclonal anti epidermal growth factor receptor antibody in colorectal cancer: another one or the one?

Related EGFR/HER2 Products
Nimotuzumab

Nimotuzumab (Nimotuzumab) is the first humanized monoclonal antibody targeting epidermal growth factor receptor (EGFR). Nimotuzumab has cytolytic effects on target tumors through its ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). Nimotuzumab failed to recognize mouse EGFR.

Matuzumab

Matuzumab (EMD 72000) is a humanized monoclonal antibody that binds tightly to EGFR.

AEE788

AEE788 (NVP-AEE788) is a novel multitargeted HER 1/2 and VEGFR 1/2 receptor family tyrosine kinases inhibitor with IC50 of 2, 6, 77, 59 nM for EGFR, ErbB2, KDR, and Flt-1.

Sapitinib (AZD8931)

AZD8931 (Sapitinib) is an equipotent, reversible inhibitor of Signaling by EGFR, ERBB2 (HER2), and ERBB3 with IC50 of 4, 3, 4 nM respectively.

Afatinib

Afatinib (BIBW 2992) is a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Panitumumab, ABX-EGF supplier, EGFR/HER2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.